Attached files

file filename
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-ex3102.htm
EX-10.1 - SIXTH AMENDMENT TO CONSULTING AGREEMENT - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-ex1001.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-ex3101.htm
EX-10.2 - EMPLOYMENT OFFER LETTER - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-ex1002.htm
EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-ex3201.htm
EX-32.2 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-ex3202.htm
EXCEL - IDEA: XBRL DOCUMENT - Brooklyn ImmunoTherapeutics, Inc.Financial_Report.xls
10-Q - NTN BUZZTIME, INC. - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-033114.htm

Exhibit 10.3

 

NTN BUZZTIME, INC.

2014 INCENTIVE BONUS

CHIEF OPERATIONS OFFICER (“EXECUTIVE”)

 

The amount of the Executive’s incentive bonus for the 2014 calendar year shall be earned by the Executive as follows:

 

·A bonus up to $28,125 if NTN Buzztime, Inc. (the “Company”), achieves certain revenue goals that are determined and approved by the Board of Directors of the Company (the “Board”).

 

·A bonus up to $28,125 if operational cost budgets that are determined ad approved by the Board are met.

 

·A bonus up to $45,000 if the Company is able to significantly improve consumer engagement. Criteria will be established by the Nominating and Corporate Governance/Compensation Committee (the “Committee”) of the Board.

 

·A bonus up to $11,250 if the Company achieves certain cost reduction goals related to the delivery of its product and platform as determined and approved by the Committee.